0001104659-26-055840
SEC filingA transition period defined by a 49% revenue decline and widening operating losses, as the company shifts focus toward constructing its continuous electrolyte production pilot line.
Total revenue fell to $3.1 million, a 49% decrease driven primarily by the timing and nature of milestone-based work under the SK On Agreements. The company completed site acceptance testing for the SK On line in April 2026, suggesting the current period represented a transition in major revenue-generating milestones. Management expects revenue recognition to continue evolving as the focus shifts to validation activities and construction of the continuous electrolyte production pilot line.
Operating loss widened to -$26.3 million from -$24.0 million in the prior year period. Management attributed the increase in costs to the electrolyte product mix, reflecting the company's strategic pivot toward scaling production capabilities. Despite the deeper operating loss, net loss improved 14% to -$13.0 million, resulting in a diluted EPS of -$0.06 compared to -$0.08 in Q1 2025. The divergence between operating and net income reflects non-operating factors impacting the bottom line.
Operating cash used in activities decreased to -$18.8 million, an improvement attributed to the timing of annual contract payments shifting to an end-of-year schedule. Other cash used in operating activities related to facility operating costs, purchases of materials from suppliers, and hazardous waste removal. Capital expenditures remained modest at $1.7 million during the quarter, but management explicitly guided that cash used for capex would increase for the remainder of the year to fund the pilot line construction. This forward-looking signal indicates the company is entering a capital-intensive phase of its development roadmap, with short-term liquidity requirements focused on installing the continuous electrolyte production pilot line. To satisfy anticipated demand, the company will need to scale production of its electrolyte, positioning the recent equity raise as a critical enabler of this strategic initiative.